Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,223.26
2,668.50
2,890.21
2,698.84
2,745.19
2,568.11
3,017.13
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,223.26
2,668.50
2,890.21
2,698.84
2,745.19
2,568.11
3,017.13
Raw Material Cost
1,117.97
1,361.39
1,292.53
1,267.30
1,142.45
1,126.62
1,176.37
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
418.93
466.88
0.00
415.38
410.85
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.77
5.68
12.68
19.27
23.13
33.94
52.85
Selling and Distribution Expenses
643.42
862.91
1,180.43
1,113.01
1,237.25
1,181.42
1,355.81
Other Expenses
-31.55
-34.55
9.34
-31.22
-28.62
10.18
5.34
Total Expenditure (Excl Depreciation)
1,866.53
2,351.38
2,579.03
2,502.75
2,527.52
2,443.78
2,638.46
Operating Profit (PBDIT) excl Other Income
356.70000000000005
317.1
311.2
196.1
217.7
124.3
378.7
Other Income
87.46
40.80
27.49
31.02
49.37
40.16
29.88
Operating Profit (PBDIT)
540.60
465.06
476.07
365.99
415.26
325.47
548.77
Interest
1.77
5.68
12.68
19.27
23.13
33.94
52.85
Exceptional Items
-38.55
-25.87
-84.31
-56.31
-16.52
12.93
-264.61
Gross Profit (PBDT)
1,105.29
1,307.11
1,597.69
1,431.54
1,602.73
1,441.49
1,840.76
Depreciation
134.93
141.08
159.69
164.38
172.24
170.81
174.34
Profit Before Tax
365.35
292.43
219.39
126.02
203.37
133.66
56.97
Tax
74.56
68.19
39.07
21.04
17.83
18.43
39.08
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
320.01
242.69
199.59
104.66
187.09
107.37
13.91
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
320.01
242.69
199.59
104.66
187.09
107.37
13.91
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-20.11
-18.77
-19.67
-0.05
-3.33
1.62
-3.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
299.90
223.92
179.91
104.60
183.76
108.99
10.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,884.24
2,892.64
2,976.19
2,970.08
2,926.98
2,778.41
2,688.97
Earnings per share (EPS)
0.46
0.34
0.26
0.14
0.24
0.14
0.02
Diluted Earnings per share
0.46
0.34
0.26
0.14
0.24
0.14
0.02
Operating Profit Margin (Excl OI)
14.31%
10.61%
10.0%
6.32%
7.05%
4.46%
11.42%
Gross Profit Margin
22.5%
16.25%
13.12%
10.76%
13.68%
11.86%
7.67%
PAT Margin
14.39%
9.09%
6.91%
3.88%
6.82%
4.18%
0.46%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -16.68% vs -7.67% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 33.94% vs 24.46% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 6.79% vs -5.42% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -68.42% vs -55.12% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Yabao Pharmaceutical Group Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
2,223.26
0
2,223.26
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,223.26
0
2,223.26
Raw Material Cost
1,117.97
0
1,117.97
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
418.93
0
418.93
Power Cost
0
0
0.00
Manufacturing Expenses
1.77
0
1.77
Selling and Distribution Expenses
643.42
0
643.42
Other Expenses
-31.55
0.00
-31.55
Total Expenditure (Excl Depreciation)
1,866.53
0
1,866.53
Operating Profit (PBDIT) excl Other Income
356.73
0.00
356.73
Other Income
87.46
0
87.46
Operating Profit (PBDIT)
540.60
0
540.60
Interest
1.77
0
1.77
Exceptional Items
-38.55
0
-38.55
Gross Profit (PBDT)
1,105.29
0
1,105.29
Depreciation
134.93
0
134.93
Profit Before Tax
365.35
0
365.35
Tax
74.56
0
74.56
Provisions and contingencies
0
0
0.00
Profit After Tax
320.01
0
320.01
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
320.01
0
320.01
Share in Profit of Associates
0
0
0.00
Minority Interest
-20.11
0
-20.11
Other related items
0.00
0.00
0.00
Consolidated Net Profit
299.90
0
299.90
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,884.24
0
2,884.24
Earnings per share (EPS)
0.46
0
0.46
Diluted Earnings per share
0.46
0
0.46
Operating Profit Margin (Excl OI)
14.31%
0%
0.00
14.31%
Gross Profit Margin
22.50%
0%
0.00
22.50%
PAT Margin
14.39%
0%
0.00
14.39%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 222.33 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -16.68% vs -7.67% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 29.99 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 33.94% vs 24.46% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 45.31 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 6.79% vs -5.42% in Dec 2024
Annual - Interest
Interest 0.18 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -68.42% vs -55.12% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.31%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






